AGP Picks
View all

AGP Executive Report

Last update: 8 hours ago

Severe Weather: Iceland issued a nationwide orange-level warning ahead of an intense storm bringing strong winds and snow. Cancer Treatment: An EU medicines committee recommended approval of daraxonrasib for adults with metastatic pancreatic cancer after prior treatment; final European Commission approval is still pending. Alcohol and Health: WHO/Europe launched a digital hub with an AI assistant to help health professionals discuss alcohol risks, including cancer. Only 15% of people surveyed knew alcohol can cause breast cancer.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Sep. 23, 2026

AlmaLinux chair to speak at Atlas Digital Summit in Reykjavik

AGP

fallback image
Oct. 15, 2026

Micro pellets fish food market seen reaching $1.89 billion by 2030

AGP

fallback image
Sep. 17, 2026

Anti-reflux infant formula market seen reaching $117.14 billion by 2030

AGP

fallback image
Aug. 26, 2026

Gallford launches surface-mounted drop-down seal for retrofit door gaps

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
Regional study on mental health and working conditions seeks participation from nursing and medical professionals in 17 countries

Regional study on mental health and working conditions seeks participation from nursing and medical professionals in 17 countries


fallback image
Oct. 15, 2026

Revolution Medicines’ RASONQUE(™) (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer

GlobeNewswire, Inc.

fallback image
Oct. 15, 2026

QUOIA Launches with All-Star Musical Collaboration Inspired by Iceland’s Wild Landscapes

EIN Presswire

fallback image
Oct. 14, 2026

Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg

GlobeNewswire, Inc.

fallback image
Sep. 25, 2026

European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

GlobeNewswire, Inc.

fallback image
Sep. 23, 2026

NV26 Readiness: 352d SOW Integrates with NATO Allies in Iceland

DVIDS - Georgia

fallback image
Sep. 18, 2026

Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Can the EU Step up Where the US is Stepping Back?
Play
Can the EU Step up Where the US is Stepping Back?
YouTube video thumbnail:  EU Member States set for Budget Clash
Play
EU Member States set for Budget Clash
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: How ASML Have Become a European AI Industry Darling
Play
How ASML Have Become a European AI Industry Darling
YouTube video thumbnail: Inside Albania's Protest Movement: What's Fanning the Flames?
Play
Inside Albania's Protest Movement: What's Fanning the Flames?

Video Title

Sign up for:

Iceland Health Focus

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Iceland Health Focus

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.